We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · March 18, 2020

Dupilumab Treatment Results in Early and Sustained Improvements in Itch in Adolescents and Adults With Moderate to Severe Atopic Dermatitis

Journal of the American Academy of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Academy of Dermatology
Dupilumab Treatment Results in Early and Sustained Improvements in Itch in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: Analysis of the Randomized Phase 3 Studies SOLO 1 & SOLO 2, AD ADOL, and CHRONOS
J Am Acad Dermatol 2020 Mar 02;[EPub Ahead of Print], JI Silverberg, G Yosipovitch, EL Simpson, BS Kim, JJ Wu, L Eckert, I Guillemin, Z Chen, M Ardeleanu, A Bansal, M Kaur, AB Rossi, NMH Graham, N Patel, A Gadkari

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading